Phibro Animal Health Corporation

Phibro Animal Health Corporation is a leading global animal health company whose core business is the development, manufacture, and sale of products for livestock, including vaccines, nutritional supplements, and antimicrobials. Its business model is predicated on the commercial exploitation of animals in industrial agriculture, specifically the confinement systems of factory farming. The company's products are designed to support and enable the large-scale production of animals for meat, dairy, and eggs, an activity covered under the animal exploitation exclusion.

The company's recent legal action underscores its commercial stake in this system. In January 2024, Phibro filed suit against the U.S. Food and Drug Administration (Case 1:24-cv-00045), challenging the agency's regulatory process. This litigation demonstrates Phibro's active defense of its product portfolio and the agricultural practices it serves. As a primary supplier to the industrial livestock sector, Phibro's operations are intrinsically linked to the commercial systems that exploit animals at scale.